Treatments & Therapies
What the research says about nattokinase, lumbrokinase, DNase, apheresis and other approaches studied for microclots and Long COVID, and what is unproven.
Start with these guides
Nattokinase for Microclots: What Studies Show About Enzyme Therapy
Does nattokinase dissolve microclots? A plain review of the lab evidence for nattokinase, lumbrokinase and serrapeptase, plus the safety risks.
Plasmapheresis and DFPP for Long COVID: Results From Japan and Germany
What DFPP and plasmapheresis remove, results from Edogawa Hospital in Tokyo, Dresden and Charité, and how they map to amyloid microclot and spike research.
Microclot Testing Labs and Treatment Centers: How to Choose
Compare microclot testing labs, research programs and apheresis or enzyme treatment options, with the questions to ask before you pay for any of them.
All treatments & therapies articles
Nattokinase Flare vs Bleeding: Microclot Symptoms and Risks
Is your nattokinase flare a healing crisis or dangerous bleeding? Learn how to distinguish reperfusion symptoms from anticoagulant risks and microclots.
Triple Therapy for Long COVID: What It Is and What the Evidence Shows
What triple anticoagulant therapy for long COVID involves, what the only published cohort found, why haematologists object, and the bleeding risks.
Protein Nanoparticles for mRNA Delivery: A Lipid-Free Alternative
How a Harvard team built ENTER, a lipid-free protein nanoparticle that carried mRNA, CRISPR and siRNA in cells and mice, and what the data can't show.
Living With Long COVID: A Practical Survival Guide for Right Now
A practical guide to living with Long COVID: what's known, what isn't, how to pace and track symptoms, red flags, and how to get more from appointments.